Format

Send to

Choose Destination
JAAD Case Rep. 2016 Dec 5;2(6):457-461. eCollection 2016 Nov.

Sirolimus for treatment of kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon.

Author information

1
College of Medicine, King Saud University, Riyadh, Saudi Arabia.
2
Department of Dermatology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

KEYWORDS:

KHE, kaposiform hemangioendothelioma; KMP, Kasabach-Merritt phenomenon; Kasabach-Merritt phenomenon; case report; kaposiform hemangioendothelioma; sirolimus; treatment; vascular

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center